Correlation Between Ocean Biomedical and Innovation1 Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ocean Biomedical and Innovation1 Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocean Biomedical and Innovation1 Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocean Biomedical and Innovation1 Biotech, you can compare the effects of market volatilities on Ocean Biomedical and Innovation1 Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocean Biomedical with a short position of Innovation1 Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocean Biomedical and Innovation1 Biotech.

Diversification Opportunities for Ocean Biomedical and Innovation1 Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Ocean and Innovation1 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ocean Biomedical and Innovation1 Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovation1 Biotech and Ocean Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocean Biomedical are associated (or correlated) with Innovation1 Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovation1 Biotech has no effect on the direction of Ocean Biomedical i.e., Ocean Biomedical and Innovation1 Biotech go up and down completely randomly.

Pair Corralation between Ocean Biomedical and Innovation1 Biotech

Given the investment horizon of 90 days Ocean Biomedical is expected to generate 52.41 times less return on investment than Innovation1 Biotech. But when comparing it to its historical volatility, Ocean Biomedical is 3.26 times less risky than Innovation1 Biotech. It trades about 0.0 of its potential returns per unit of risk. Innovation1 Biotech is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  20.00  in Innovation1 Biotech on October 27, 2024 and sell it today you would lose (19.90) from holding Innovation1 Biotech or give up 99.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ocean Biomedical  vs.  Innovation1 Biotech

 Performance 
       Timeline  
Ocean Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocean Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Innovation1 Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innovation1 Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Innovation1 Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Ocean Biomedical and Innovation1 Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ocean Biomedical and Innovation1 Biotech

The main advantage of trading using opposite Ocean Biomedical and Innovation1 Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocean Biomedical position performs unexpectedly, Innovation1 Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovation1 Biotech will offset losses from the drop in Innovation1 Biotech's long position.
The idea behind Ocean Biomedical and Innovation1 Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Correlations
Find global opportunities by holding instruments from different markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
CEOs Directory
Screen CEOs from public companies around the world